ERBB2 (also known as HER2) leads to malignancies because of overexpression or amplified, particularly in breast cancer, bladder cancer, lung cancer, ovarian cancer, and so forth.25 The gene discussed is ERBB2; the disease is urinary bladder carcinoma.